21st Aug 2008 11:31
Sinclair Pharma plc
Additional listing
Godalming, UK, 21 August 2008: Sinclair Pharma plc (SPH.L) (the "Company"), the international specialty pharmaceutical company, today announces that application has been made for 433,690 ordinary shares of 1 pence each (the "New Ordinary Shares") in the Company to be admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange. The New Ordinary Shares rank pari passu in all respects with the existing issued ordinary shares on the Company and it is expected that dealings will commence on 22 August 2008.
The New Ordinary Shares are being issued in final settlement of the earn-out entitlement for Europe Finance SAS following the acquisition of Groupe CS Dermatologie SAS announced on 13 March 2006.
Enquiries
For further information please contact:
Sinclair Pharma plc - Tel: +44 (0)1483 410 600
Dr Michael Flynn, CEO
Jerry Randall, CFO
Landsbanki Securities - Tel: +44 (0)20 7426 9000
Shaun Dobson
Claes Spång
Investec - Tel: +44 (0)20 7597 4000
Richard Jones
Patrick Robb
Daniel Adams
Capital MS&L - Tel +44 (0)20 7307 5340
Mary Clark
Anna Mitchell
Related Shares:
Sinclair Pharma